Clinical Trial Update: AI-PROGNOSIS - Digital Biomarkers Development Study (dBM-DEV)

View source ↗

Summary

This document reports the AI-PROGNOSIS dBM-DEV study, a Parkinson disease trial focused on developing digital biomarkers; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson Disease | Status: NOT_YET_RECRUITING